Frequently Asked Questions (FAQs)
1. Will NHIC claim any IP ownership or royalty revenue?
NHIC does not take ownership of any IP or any share of commercialisation revenue.
2. Are there any specific medical specialty or focus areas for the I2D grants?
No. Applicants can submit in the areas of Therapeutics, BioTech, MedTech, and Health Services. However, there must be a clearly defined clinical unmet need for the project.
3. Why do I need to go through my healthcare cluster (this is not usual practice for grant applications)?
It is so NHIC can have a common contact point for all the institutions under the six healthcare clusters for the management of the grants and commercialisation.
4. Who can I approach in my healthcare cluster to endorse my I2P or I2D grant applications?
See the below table or contact firstname.lastname@example.org
|National University Health System (NUHS)||
||NUHS Research Office|
|Singapore Health Services (SingHealth)||
||SingHealth Office of Research|
|National Healthcare Group (NHG)||
||NHG Research & Development Office|
|Eastern Health Alliance (EHA)||
||EHA Centre of Innovation|
|Alexandra Health System (AHS)||
||KTPH Clinical Research Unit|
|Jurong Health Services (JHS)||
||Jurong Health Research Office|